02/19/2021
4:14 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2021
4:10 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13G
| |
02/12/2021
3:44 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2021
8:55 PM | Infinity Pharmaceuticals (Filer)
| Form S-3MEF
| |
02/11/2021
6:16 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2021
4:27 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2021
4:26 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
01/26/2021
11:21 AM | EcoR1 Capital, LLC (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13G
| |
01/06/2021
8:17 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2020
3:05 PM | Infinity Pharmaceuticals (Issuer)
Tasker Seth A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/09/2020
8:13 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2020
4:13 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
11/09/2020
3:16 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2020
6:41 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2020
5:48 PM | Infinity Pharmaceuticals (Subject)
Opaleye Management Inc. (Filed by)
| Form SC 13G
| |
08/25/2020
7:05 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2020
6:04 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2020
6:03 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2020
9:43 AM | Infinity Pharmaceuticals (Filer)
| Form CT ORDER
| |
06/18/2020
3:22 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2020
7:34 AM | Infinity Pharmaceuticals (Issuer)
VENUTI MICHAEL C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2020
7:33 AM | Infinity Pharmaceuticals (Issuer)
SELBY NORMAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2020
7:30 AM | BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2020
7:30 AM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2020
7:30 AM | EVNIN ANTHONY B (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2020
7:40 AM | Infinity Pharmaceuticals (Filer)
| Form DEFA14A
| |
05/11/2020
6:37 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2020
6:24 AM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/27/2020
7:30 AM | Infinity Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/07/2020
6:47 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2020
6:48 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2020
7:00 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2020
8:58 AM | Infinity Pharmaceuticals (Filer)
| Form CT ORDER
| |
01/13/2020
4:01 PM | Infinity Pharmaceuticals (Issuer)
Tasker Seth A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
4:01 PM | BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
4:01 PM | Infinity Pharmaceuticals (Issuer)
Kutok Jeffery (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
4:00 PM | Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
7:00 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2020
4:22 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
01/09/2020
6:43 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2019
2:13 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/16/2019
6:18 PM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
6:14 PM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/22/2019
3:05 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2019
7:32 AM | Infinity Pharmaceuticals (Filer)
| Form 424B5
| |
07/30/2019
6:44 AM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2019
6:35 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2019
3:26 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2019
3:06 PM | EVNIN ANTHONY B (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:06 PM | Infinity Pharmaceuticals (Issuer)
SELBY NORMAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:06 PM | BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:05 PM | Infinity Pharmaceuticals (Issuer)
VENUTI MICHAEL C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:05 PM | BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:05 PM | Infinity Pharmaceuticals (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:05 PM | Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:05 PM | Berkowitz Jeffrey (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
6:32 AM | Infinity Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/13/2019
3:56 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2019
3:11 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2019
2:16 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2019
11:15 PM | Infinity Pharmaceuticals (Filer)
| Form EFFECT
| |
04/24/2019
7:30 AM | Infinity Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/08/2019
4:03 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2019
9:10 AM | Infinity Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/14/2019
6:38 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2019
6:06 AM | Infinity Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2019
6:53 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2019
7:00 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2019
3:07 PM | Infinity Pharmaceuticals (Issuer)
Tasker Seth A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
3:06 PM | BLOCH LAWRENCE E (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
3:05 PM | Infinity Pharmaceuticals (Issuer)
Kutok Jeffery (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
3:05 PM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
3:05 PM | Infinity Pharmaceuticals (Issuer)
Perkins Adelene Q (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
6:46 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2018
6:40 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
5:28 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2018
4:57 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2018
4:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
11/15/2018
7:07 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
2:33 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/30/2018
11:00 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2018
4:10 PM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2018
4:05 PM | Agresta Samuel (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2018
3:13 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2018
2:27 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/26/2018
10:52 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2018
4:00 PM | Infinity Pharmaceuticals (Issuer)
Kutok Jeffery (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2018
5:57 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Infinity Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2018
4:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Infinity Pharmaceuticals (Subject)
| Form SC 13D/A
| |
06/14/2018
7:37 AM | Infinity Pharmaceuticals (Issuer)
SELBY NORMAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:35 AM | Berkowitz Jeffrey (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:34 AM | Infinity Pharmaceuticals (Issuer)
SMITH IAN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:33 AM | EVNIN ANTHONY B (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:32 AM | Infinity Pharmaceuticals (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:31 AM | Infinity Pharmaceuticals (Issuer)
VENUTI MICHAEL C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2018
7:30 AM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2018
7:30 AM | BEIER DAVID W (Reporting)
Infinity Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2018
11:15 PM | Infinity Pharmaceuticals (Filer)
| Form EFFECT
| |
05/08/2018
3:12 PM | Infinity Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2018
2:36 PM | Infinity Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
